2018年　論文・総説（国際）

2018 論文・総説（国際）~Publications(International)~

1	Effect of a SGLT2 inhibitor on the systemic and intrarenal renin-angiotensin system in subtotally nephrectomized rats. Li L, Konishi Y, Morikawa T, Zhang Y, Kitabayashi C, Kobara H, Masaki T, Nakano D, Hitomi H, Kobori H, Nishiyama A. J Pharmacol Sci. Volume 137, Issue 2, June 2018, Pages 220-223 .
2	Hypertension with diabetes mellitus complications. Yamazaki D, Hitomi H, Nishiyama A. Hypertens Res. 2018 Mar;41(3):147-156.
3	Combined therapy with gas gangrene antitoxin and recombinant human soluble thrombomodulin for Clostridium perfringens sepsis in a rat model. Hifumi T, Nakano D, Chiba J, Takahashi M, Yamamoto A, Fujisawa Y, Kawakita K, Kuroda Y, Nihsiyama A. Toxicon. 2018 Jan;141:112-117.
4	Simultaneous GLP-1 receptor activation and angiotensin receptor blockade increase natriuresis independent of altered arterial pressure in obese OLETF rats. Rodriguez R, Moreno M, Lee1 AY, Godoy-Lugo JA, Nakano D, Nishiyama A, Parkes DG, Awayda MS, Ortiz RM. Hypertens Res. 2018 Oct;41(10):798-808.
5	Altered circadian timing system-mediated non-dipping pattern of blood pressure and associated cardiovascular disorders in metabolic and kidney diseases. Rahman A, Hasan AU, Nishiyama A, Kobori H. Int J Mol Sci. 2018 Jan 30;19(2). pii: E400.
6	A novel approach to adenine-induced chronic kidney disease associated anemia in rodents. Rahman A, Yamazaki D, Sufiun A, Kitada K, Hitomi H, Nakano D, Nishiyama A. PLoS ONE. 2018 Feb 7;13(2):e0192531.
7	Guanylyl cyclase A in both renal proximal tubular and vascular endothelial cells protects the kidney against acute injury in rodent experimental endotoxemia models. Kitamura H, Nakano D, Sawanobori Y, Asaga T, Yokoi H, Yanagita M, Mukoyama M, Tokudome T, Kangawa K, Shirakami G, Nishiyama A. Anesthesiology. 2018 Aug;129(2):296-310. doi: 10.1097/ALN.0000000000002214.
8	Independent regulation of renin-angiotensin-aldosterone system in the kidney. Nishiyama A, Kobori H. Clin Exp Nephrol. 2018 Dec;22(6):1231-1239.
9	Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response. Strausser SA, Nakano D, Souma T. Curr Opin Nephrol Hypertens. 2018 Jul;27(4):314-322. doi: 10.1097/MNH.0000000000000424.
10	Effects of Olmesartan and Azilsartan on Albuminuria and the Intrarenal Renin-Angiotensin System. Takami T, Okada S, Saito Y, Nishijima Y, Kobori H, Nishiyama A. World J Res Rev. 2018 Jan;6(1):7-10.
11	Add-on effect of angiotensin receptor blockade (candesartan) on clinical remission in active IgA nephropathy patients treated with steroid pulse therapy and tonsillectomy: a randomized, parallel-group comparison trial. Kohagura K, Arima H, Miyasato H, Chang TH, Yamazato M, Kobori H, Nishiyama A, Iseki K, Ohya Y. Kidney Blood Press Res 2018; 43(3): 780-792.
12	Chronic AT1 blockade improves glucose homeostasis in obese OLETF rats. Rodriguez R, Minas JN, Vazquez-Medina JP, Nakano D, Parkes DG, Nishiyama A, Ortiz RM. J Endocrinology. 2018 Jun;237(3):271-284.
13	Angiotensin receptor blockade improves cardiac mitochondrial activity in response to an acute glucose load in obese insulin resistant rats. Thorwald M, Rodriguez R, Lee A, Martinez B, Peti-Peterdi J, Nakano D, Nishiyama A, Ortiz RM. Redox Biol. 2018 Apr; 14: 371-378.
14	Ultrasonic standing wave preparation of a liquid cell for glucose measurements in urine by midinfrared spectroscopy and potential application to smart toilets. Yamamoto N, Kawashima N, Kitazaki T, Mori K, Kang H, Nishiyama A, Wada K, Ishimaru I. J Biomed Opt. 2018 May;23(5):1-4.
15	Gene expression changes in the retina after systemic administration of aldosterone. Ono A, Hirooka K, Nakano Y, Nitta E, Nishiyama A, Tsujikawa A. Jpn J Ophthalmol. 2018 Jul;62(4):499-507. doi: 10.1007/s10384-018-0595-4. Epub 2018 Apr 30.
16	A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice. Zhang Y, Nakano D, Guan Y, Hitomi H, Uemura A, Masaki T, Kobara H, Sugaya Y, Nishiyama A. Kidney Int. 2018 Sep;94(3):524-535.
17	The Sendai declaration for the eradication of kidney disease. Kashihara N, Nangaku M, Ito S, Nishiyama A, Harris D. Clin Exp Nephrol (2018) 22(1):1-2.
18	The effects of sodium-glucose cotransporter 2 inhibitors on sympathetic nervous activity. Wan N, Rahman A, Hitomi H, Nishiyama A. Front Endocrinol. 26 July 2018 \| https://doi.org/10.3389/fendo.2018.00421
19	A novel role of renin inhibitor in the complement cascade. Nakano D, Nishiyama A. Kidney Int. 2018 Oct;94(4):650-652.
20	Tubular cell senescence in the donated kidney predicts allograft function, but not donor remnant kidney function, in living donor kidney transplantation. Sofue T, Kushida Y, Ozaki T, Moritoki M, Nishijima Y, Ohsaki H, Ueda N, Kakehi Y, Nishiyama A, Minamino T. Am J Nephrol. 2018, 47(1):8-17.
21	Angiotensin receptor and tumor necrosis factor-α activation contributes to glucose intolerance independent of systolic blood pressure in obese rats. Rodriguez R, Lee A, Mathis KW, Broome HJ, Thorwald M, Martinez B, Nakano D, Nishiyama A, Ryan MJ, Ortiz RM. Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F1081-F1090.
22	Effects of the selective chymase inhibitor TEI-F00806, on the intrarenal renin-angiotensin system in salt-treated angiotensin I-infused hypertensive mice. Ansary TM, Urushihara M, Fujisawa Y, Nagata S, Urata H, Nakano D, Hirofumi H, Kitamura K, Kagami S, Nishiyama A. Exp Physiol. Nov 2018 Nov; 103(11): 1524-1531.
23	Klotho ameliorates medullary fibrosis and pressure natriuresis in hypertensive rat kidneys. Takenaka T, Inoue T, Miyazaki T, Kobori H, Nishiyama A, Ishii N, Hayashi M, Suzuki H. Hypertension. 2018 Nov;72(5):1151-1159.
24	Involvement of complement 3 in the salt-sensitive hypertension by activation of renal renin-angiotensin system in spontaneously hypertensive rats. Negishi E, Fukuda N, Otsuki T, Katakawa M, Komatsu K, Chen L, Tanaka S, Kobayashi H, Hatanaka Y, Ueno T, Endo M, Mashimo T, Nishiyama A, Abe M. Am J Physiol Renal Physiol. 2018 Dec 1; 315(6): F1747-F1758
25	The Japanese Society of Hypertension-Digest of plan for the future. Node K, Kishi T, Tanaka A, Itoh H, Rakugi H, Ohya Y, Miura K, Okamura T, Ishimitsu T, Ichihara A, Ito M, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nakamura S, Nishiyama A, Hasebe N, Higaki J, Tamura K, Kawano Y, Yatabe T, Ito S; JSH Future Plan Working Group and Executive Board Members. Hypertens Res. 2018 Dec;41(12):989-990.
26	Summary of the 2018 ISN Frontiers Meeting: Kidney Disease and Cardiovascular Disease. Shinji Kume, Hajime Nagasu, Masaomi Nangaku, Akira Nishiyama, Hidetomo Nakamoto, Naoki Kashihara. Kidney International Reports 3(4) 804 - 816.
27	Commentary for Aliskiren inhibits renin-mediated complement activation. Nakano D, Nishiyama A. Kidney Int. 2018 Jul.
28	Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula. Kala P, Sedlakova L, Skaroupkova P, Kopkan L, Vanourkova Z, Taborsky M, Nishiyama A, Hwang SH, Hammock BD, Sadowski J, Melenovsky V, Imig JD, Cervenka L. Physiol Res. 2018; 67(3): 401-415.